{"name":"Beijing Union Pharmaceutical Factory Ltd","slug":"beijing-union-pharmaceutical-factory-ltd","ticker":"","exchange":"","domain":"beijingunionfactory.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Buagafuran","genericName":"Buagafuran","slug":"buagafuran","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Buagafuran","genericName":"Buagafuran","slug":"buagafuran","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxOLWUxMl9ic1htZlVVQU4xVkh3TzY4VFcwaTNFUFZranJldTUweUtfOE5ycEtya2tmZnJsVHF5UVRjQTFUNXNDeXluOHMwTERUS1k1ZnlwUmNBeVBmUEZDTUoxWTYzNlNnT0tVVTIyMlk1LWJwWXN5OHRHYjV1M3ZnS2FXNzY1LUFsbDZLc21CVVFRUmdIM2xMM1czSHdQUDlwWmw5bVk1QUt2VmJXRDY3NHBwRWxDRU5jb1AzZ3ZkcG9kSUNFMHZDX1IxaE45N2YyTTNsMldIZzc5U1lWOVhvYkFQcmhHUDVZaXgwbTBtX2tOSXJ5V1h3TGVCNkE5WnQ2d05jSzdlZTJHSm9CdXVwdTNEeFJVa1ZteUhodg?oc=5","date":"2026-03-30","type":"deal","source":"Via TT","summary":"Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform - Via TT","headline":"Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platf","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPaUgtbFhENFNrVVBVMkZseTdBWk5ZQ3IzN25DYXVfS2FnUGgwY2R5aHhUWTNlSW1uQ3lBWTY3UEx6ZnN3TDFNeHdraW11YWdKajJhUllxbnB3SXlqNnFXbVQ1WndPbVh0OGJMalZFZmJnS0QwdXVZZ3FabkJFWGh2c0tTSWRfeEJNSWdCUDVTWmpuTXJuRjQ3b00wSDNRMVBBRjdpM0VoQ1JwWi1qQWpBT1FR?oc=5","date":"2025-12-02","type":"pipeline","source":"AFR","summary":"China draws in Europe’s businesses despite alarm over competition - AFR","headline":"China draws in Europe’s businesses despite alarm over competition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5YY0NxR2lyRktsTmhnNzRnUVJkclI4UF92bkdSSTVoLUdGU0xjT0VOX0k2SG1rVGd4X3dIWUMtWmEwdXlFejhaaVlqemVuMUZQR3psTlNXNktHaGZpc1gw?oc=5","date":"2025-11-06","type":"pipeline","source":"nature.com","summary":"What the launch of the African Medicines Agency means for drug and health regulation - nature.com","headline":"What the launch of the African Medicines Agency means for drug and health regulation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNWHB0YWh6Y2VBNFY1cVJUUENEVmFKcFhmRm91ckhnSXA3cXpZSGZydGFsMmdJeHFFakNTYmd0WEhMbFFBdEJJUmN6dl9SUjdhXzEtMzdIazVEckpOdnR1RTNZR3hXVEdkQ3Z2UWJCY2NhUGZMWjMzOTl5a1AxdzgzckdVVU1KM00wOG4xdTVUNkZYeUdHR0tJTDBlMTNhUGEtb3FOU1IzX0xWUGd1SXowSDdGY2RVVmpYa19aQk5YTGZnN3BicHdkNnhPdm53NkYxVkNQNE1SMUtvWGp0V3gxMmR3?oc=5","date":"2025-04-25","type":"pipeline","source":"Reuters","summary":"US business lobby in China: Some pharma firms reporting tariff exemptions - Reuters","headline":"US business lobby in China: Some pharma firms reporting tariff exemptions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQamdDM0dqdEJUQjJZVElTOTBvbnFYc1ltNzJTOG0zamJXc1RLSUo0QXozRDVfQVQ2bmpBd2FtLUFjd1dDRFlwNE9mbi1rcU5CZEw3UjF0N2lmSXAxWXllR1NxVTZKc0RvQU9NOHc0MmxfTjQtVEdLTnNtWFJCUUd2ZXBQMlVPNmN1NGNxWjVhZUZXTVI2X1A3b1lCVGJCNE0ySWczTEhpRDVYQ3J1Q1B4d094bjdLc2RXM1NPODBoU0MtZlJfZm0xaGVJY0phUm1aTzk2UXA5YkdfY1VQS2d1NA?oc=5","date":"2025-03-14","type":"pipeline","source":"Reuters","summary":"China should not prioritise low prices in drug procurement plan, European lobby group says - Reuters","headline":"China should not prioritise low prices in drug procurement plan, European lobby group says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOMVZKNzZ5LUdsSWxIb0RqRTkxVjVXLVlpSDI4bnc0a0gzX3lBanU1QnZwU3lkUEJoVkZzeUI0MGFUTmIyRnJjd1dLUXpBd0xGWnBKakRDU3JNUENGMXF5MGlMVng3LU5BaXZaMy1ORURKWXFLaFBTTGZPd3lHMW44N2hB?oc=5","date":"2023-05-30","type":"pipeline","source":"China Daily - Global Edition","summary":"Sanofi to up synergy with Chinese pharma market - China Daily - Global Edition","headline":"Sanofi to up synergy with Chinese pharma market - China Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9jdkJnVkp1cG1QY1dLZ0ptTTJTUXRVN0pSNi1hREVaYkZBdmF6UlNHR2hqTGpVTEc3V25NREdGMHg1MmJwNFI2OEREQ0NGTWhDMThNcDM4eDBKbjZ0ZjV0LXFfelh6ZG5Xanh2RmZnVDRJQkVLdjVyck9RTQ?oc=5","date":"2023-04-25","type":"pipeline","source":"politico.eu","summary":"The real reason Europe’s medicines industry is dying - politico.eu","headline":"The real reason Europe’s medicines industry is dying","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-04-07","type":"pipeline","source":"Down To Earth","summary":"COVID-19 exposes India’s dependence on China for active pharma ingredients - Down To Earth","headline":"COVID-19 exposes India’s dependence on China for active pharma ingredients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPb2lyUUxzbE1Vamg5UUlrdmd6M29HeFJqSDZjbnZwTXJ3anJBSTBPYXBkR3NyRU4xRXRTOTB0OHNyS1lqcmFNbGowNDYzWV93OHpHaEZNNGpweVprM2xNcVJaWWtYYllRS3dnOUxncjRaNk9CZ2tLblJyaTVMSVg2c0o5S2F6T3Btanh3UmpWdVRndWdSVENGZ0NuREctS1o1VkxLQXVaQXZOcENuSEQxTmJFZlFsZ01LSXFadU8wSzJUZ3Q2LU9pRHMwa1ZkSnEzd3NRMTd0clBOZkFJTFd0ZFBjd0JUd3l4cWlFYXRGQmNxSnRHUWJUX0FtWS1NZw?oc=5","date":"2020-03-16","type":"deal","source":"PR Newswire","summary":"Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy - PR Newswire","headline":"Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNcU5VLXFVeEs0cVk5cHpFTGxhRDNYRnppekgzVkJ0TlFOUmxIU3Q2czUtbkVfSmM5YmctMWdXenQtOFp4ZDZ0RnItMTZkUXVoTGw3eUhocEd2ZGJBN2hDMnZOQ1doQzBmSF9fZlMxM2xnbDBDZHRBMGVRMmFHM2VhOUlrSXFLRG1fU2VHN2E0cFdjUjQ2RHQzeWYwbkNRT1R2TGpBdl8xVzlQejlNYVFZNkNUalpSTTJVWldV?oc=5","date":"2018-09-28","type":"regulatory","source":"Caixin Global","summary":"Novartis Bets on Beijing Approving Cutting-Edge Cancer Treatment - Caixin Global","headline":"Novartis Bets on Beijing Approving Cutting-Edge Cancer Treatment","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2017-09-11","type":"pipeline","source":"South China Morning Post","summary":"Fosun Pharma adopts Xiaomi’s strategy in taking on western rivals - South China Morning Post","headline":"Fosun Pharma adopts Xiaomi’s strategy in taking on western rivals","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}